The beckley Foundation

From the Beckley Foundation Site

Our research with Psilocybin

In 2016, the Beckley/Imperial Research Programme released a study that revealed the staggering potential of psilocybin to alleviate treatment-resistant depression, with 67 percent being depression free after one week and 42 percent remaining in remission three months later. Collaborating with highly prestigious universities, the Beckley Foundation has also conducted research indicating the efficacy of psilocybin as an aid to smoking cessation. Using the latest brain-imaging techniques, we have shed some light on how psilocybin may produce its therapeutic effects, by generating a more ‘entropic’ pattern of brain connectivity, with increased communication throughout the brain leading to more flexible modes of cognition.

Find out more

Psilocybin for Depression

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Read me

Just click back to return to our site

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Read me

Just click back to return to our site

Support Psychedelic Reasearch & Drug Policy reform with Donation to the Beckley Foundation

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Support Psychedelic Reasearch & Drug Policy reform with Donation to the Beckley Foundation

Read me

Just click back to return to our site

The Beckley Foundation Microdose Study

From the Beckley Foundation Site

Our research with Psilocybin

Psilocybin for Depression

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Support Psychedelic Reasearch & Drug Policy reform with Donation to the Beckley Foundation

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression

Support Psychedelic Reasearch & Drug Policy reform with Donation to the Beckley Foundation

Welcome to the site.